Kumovis Founders Launch Munich Medical Devices for 3D-Printed PEEK Implants

A familiar team returns

The founders of Kumovis have launched a new company, Munich Medical Devices GmbH, aimed at producing patient-specific implants from PEEK and other high-performance thermoplastics. The group previously built Kumovis into a successful medical 3D printing platform before it was acquired by 3D Systems in 2022. Now they are starting fresh with a narrower focus on implants rather than the broader printer ecosystem they developed before.

Why PEEK matters

PEEK is a material that sits in an awkward spot. It is strong, lightweight, and biocompatible, which makes it attractive for spinal cages, cranial plates, and trauma hardware. It is also notoriously difficult to print consistently. Most off-the-shelf 3D printers struggle with the temperatures and thermal control that PEEK demands. Kumovis's original technology was built specifically to solve that problem, and Munich Medical Devices inherits that process expertise without having to rebuild the underlying extrusion system from scratch.

The business case

The new venture is targeting hospitals and implant manufacturers that want decentralized, on-demand production of customized parts. Traditional implant manufacturing relies on long lead times and inventory that may never be used if a patient's anatomy does not match the standard sizes. 3D printing cuts that inventory down to a digital file and a spool of material, with production happening close to the point of care.

Regulatory compliance remains the biggest hurdle. Medical implants require FDA clearance or CE marking, and every change in geometry or material batch can trigger a new validation cycle. Munich Medical Devices will need to show that its process is repeatable and traceable if it wants to move beyond pilot programs into routine clinical use.

What comes next

There is no product catalog or shipping timeline yet. The company is in an early stage, focusing on process development and partnership discussions. Given the team's track record, the technology is credible. The question is whether the market is ready for another PEEK implant entrant, or if hospitals have already settled on their preferred suppliers. The next 12 months will likely answer that.